ChemicalBook > Product Catalog >API >Hormones and the Endocrine System >Erectile Dysfunction Treatment >Darifenacin

Darifenacin

Darifenacin Structure
CAS No.
133099-04-4
Chemical Name:
Darifenacin
Synonyms
CS-773;UK88525;UK-88525;UK 88525;DARIFENACIN;Darifenacin, >=98%;Darifenacin USP/EP/BP;Tolafentrine Impurity 16;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe
CBNumber:
CB1506695
Molecular Formula:
C28H30N2O2
Molecular Weight:
426.55
MOL File:
133099-04-4.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:01

Darifenacin Properties

alpha 25D -20.6° (c = 1.0 in methylene chloride)
Boiling point 614.3±55.0 °C(Predicted)
Density 1.192±0.06 g/cm3(Predicted)
storage temp. 2-8°C
solubility Soluble in DMSO
form Powder
pka pKa (25°): 9.2
color White to off-white

Darifenacin Chemical Properties,Uses,Production

Uses

Treatment for an overactive bladder.

Definition

ChEBI: 2-[(3S)-1-Ethylpyrrolidin-3-yl]-2,2-diphenylacetamide in which one of the hydrogens at the 2-position of the ethyl group is substituted by a 2,3-dihydro-1-benzofuran-5-yl group. It is a selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, and is used as the hydrobromide salt in the management of urinary incontinence.

Global( 127)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Venkatasai Life Sciences +91-9908134868 +91-8008303069 Hyderabad, India 186 58 Inquiry
Glenmark Pharmaceuticals Limited +912240189999 Maharashtra, India 93 58 Inquiry
AKASH PHARMA EXPORTS +91-9388123451 +91-9846039283 Kerela, India 470 58 Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
Parth Antibiotics Pvt Ltd. +91 (22) 2562-8329 New Delhi, India 173 50 Inquiry
OCEAN TRADING CORPORATION +91(22) 24921669 New Delhi, India 6211 58 Inquiry
Lexine Technochem Private Limited 07942564658 Vadodara, India 69 58 Inquiry
Abil Chem Pharma Private Limited 08068442238Ext 530 Mumbai, India 5 58 Inquiry
P. R. Pharma Source Private Limited 08048361295Ext 104 Mumbai, India 9 58 Inquiry
JSK Chemical 98797 67970 Gujarat, India 291 58 Inquiry
2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetaMide UK 88525 UK88525 UK-88525 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip Darifenacin, >=98% DARIFENACIN 2-[1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dipheny 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe CS-773 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, (3S)- Darifenacin USP/EP/BP (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α-α-diphenyl-3-pyrrolidineacetamide Hydrobromide Tolafentrine Impurity 16 133099-04-4 Pharmaceutical material and intermeidates API